John B. Henneman III - Jun 14, 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ John B. Henneman, III
Stock symbol
ANIK
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 04:16 PM
Previous filing
May 19, 2023
Next filing
Aug 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +6.5K +27.74% $0.00 29.9K Jun 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.